Medpace Voice

Watch this on-demand presentation about imaging data quality and how the advancements in AI and machine learning help track the quality of images, assess issues…

Our experts explore the medical, operational, imaging, and regulatory considerations for radiopharmaceutical dosimetry.

In this new whitepaper, experts from Medpace and Medidata discuss the recent advances in artificial intelligence and machine learning and the benefits of using this technology…

This brand new infographic explores the different types of imaging techniques, their advantages, limitations, and how they can be successfully implemented in clinical trials.

The International Liver Congress (ILC) took place digitally this year, but it was worth logging in to keep up-to-date on the novel findings in imaging…

In a new article, experts from Medpace’s radiation oncology, imaging, regulatory, and operational teams discuss the growing space of radiopharmaceutical development.

Medpace is excited to announce an agreement with Medidata to integrate imaging and clinical data into a single platform. The MCL-Medidata partnership offers Sponsors seamless…

Medpace Core Laboratories successfully completed a comprehensive inspection by the FDA on a late phase, registrational, oncology trial. The inspection concluded with no major or…

As more agents approach the clinic, it is imperative for researchers to consider the design and conduct of immuno-oncology clinical trials. Given the diversity of…

Medpace Imaging Core Laboratory, Associate Director, Dr. Scott Holland, had an opportunity to sit down with Dr. Bashir to discuss all things NASH imaging. In the…